Eosinophilic fasciitis successfully treated with cyclosporine

Clinical Rheumatology

Volumn 24, Issue 6, 2005, Pages 634-636

  Bukiej, Aleksandra ^a   Dropiński, Jerzy ^a   Dyduch, Grzegorz ^b   Szczeklik, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

Cyclosporine; Eosinophilic fasciitis

Indexed keywords

C REACTIVE PROTEIN; CIMETIDINE; CORTICOSTEROID; CYCLOSPORIN; IMMUNOGLOBULIN E; PREDNISOLONE;

ADULT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG RESPONSE; EOSINOPHILIA; EOSINOPHILIC FASCIITIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; JOINT CONTRACTURE; LABORATORY DIAGNOSIS; MUSCLE BIOPSY; MYOFIBROSIS; PRIORITY JOURNAL; REMISSION; SCLERODERMA;

CYCLOSPORINE; EOSINOPHILIA; FASCIITIS; FEMALE; FIBROSIS; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MIDDLE AGED; MUSCLE, SKELETAL; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 27844481019     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-005-1099-4     Document Type: Article

References (17)

1. Shulman LE (1974) Diffuse fasciitis with hypergammaglobulinemia and eosinophilia: A new syndrome? J Rheumatol 1 [Suppl]:46
2. Mosconi S, Streit M, Bronimann M, Braathen LR (2002) Eosinophilic fasciitis (Shulman syndrome). Dermatology 205:204-206 10.1159/000063916
3. Pouplin S, Daragon A, Le Loet X (1998) Treatment of eosinophilic fasciitis with methotrexate. J Rheumatol 25:606-607 1:STN:280:DyaK1c7ns12ksQ%3D%3D
4. Dziadzio L, Kelly EA, Panzer SE, Jarjour N, Huttenlocher A (2003) Cytokine abnormalities in a patient with eosinophilic fasciitis. Ann Allergy Asthma Immunol 90:452-455 12722970
5. Uckun A, Sipahi T, Akgun D, Oksal A (2002) Eosinophilic fasciitis successfully treated with oral hydroxyzine: A new therapeutic use of an old drug? Eur J Pediatr 161:118-119 10.1007/s00431-001-0871-y
6. Naschitz JE, Yeshurun D, Rosner J, Abrahamson JE, Misselevitcg I, Boss JH (1990) Treatment with cimetidine of atypical fasciitis panniculitis syndrome. Ann Rheum Dis 49:788-792 1:STN:280:By6D2MzjtFY%3D
7. Romano C, Rubegni P, Aloe G, Stanghellini E, Ascenzo GD, Andreassi L, Fimiani M (2003) Extracorporeal photochemotherapy in the treatment of eosinophilic fasciitis. JEADV 17:10-13 1:STN:280:DC%2BD3s%2FptFSqsQ%3D%3D
8. Drosou A, Kirsner RS, Welsh E, Sullivan TP, Kerdel FA (2003) Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J Cutan Med Surg 7:382-386
9. Plotz SG, Simon H, Darsow U, Simon D et al (2003) Use of anti-interleukin-5 antibody in the hypereosinophilic syndrome with eosinophilic dermatitis. N Engl J Med 349:2334-2339 10.1056/NEJMoa031261
10. Capella GL, Casa-Alberighi OD, Finzi AF (2001) Therapeutic concepts in clinical dermatology: Cyclosporine A in immunomediated and other dermatoses. Int J Dermatol 40:551-559 10.1046/j.1365-4362.2001.01257.x
11. Laneuville P (1992) Cyclosporin A induced remission of CD4+ T-CLL associated with eosinophilia and fasciitis. Br J Haematol 80:252-254 1:STN:280:By2C1MfotVE%3D
12. Fleming CJ, Clarke P, Kemmet D (1997) Eosinophilic fasciitis with myelodysplasia responsive to treatment with cyclosporin. Br J Dermatol 136:297-299 1:STN:280:ByiB387ntFw%3D
13. Peter RU, Ruzicka T (1992) Cyclosporin A in the therapy of inflammatory dermatoses. Hautarzt 43:687-694 1:STN:280:ByyC3cnnvFw%3D
14. Gisslinger H, Burghuber OC, Stacher G, Schwarz W, Punzengruber C, Graninger W et al (1991) Efficacy of cyclosporin A in systemic sclerosis. Clin Exp Rheumatol 9:383-390 1:STN:280:By2D3srotlc%3D
15. Worl B, Hein R, Krieg T, Meurer M (1990) Cyclosporine A in localized and systemic sleroderma - a clinical study. Dermatologica 181:215-220 2269381
16. Hayashi N, Igarashi A, Matsuyama T, Harada S (2000) Eosinophilic fasciitis following exposure to trichloroethylene: Successful treatment with cyclosporin. Br J Dermatol 142:830-832 10.1046/ j.1365-2133.2000.03446.x
17. Lohi J, Kaharai VM, Keski-Oja J (1994) Cyclosporin A enhances cytokine and phorbol ester-induced fibroblast collagenase expression. J Invest Dermatol 102:938-944 10.1111/1523-1747.ep12384105